key: cord-0254803-lxqbtzkw
authors: Jeong, Gi Uk; Lyu, Jaemyun; Kim, Kyun-Do; Chung, Young Cheul; Yoon, Gun Young; Lee, Sumin; Hwang, Insu; Shin, Won-Ho; Ko, Junsu; Lee, June-Yong; Kwon, Young-Chan
title: SARS-CoV-2 Infection of Microglia Elicits Pro-inflammatory Activation and Apoptotic Cell Death
date: 2022-01-05
journal: bioRxiv
DOI: 10.1101/2022.01.04.475015
sha: 1531417f6fd1c2a8a7687d6f327fdc8b89df3cc9
doc_id: 254803
cord_uid: lxqbtzkw

Accumulating evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes various neurological symptoms in coronavirus disease 2019 (COVID-19) patients. The most dominant immune cells in the brain are microglia. Yet, the relationship between neurological manifestations, neuroinflammation, and host immune response of microglia to SARS-CoV-2 has not been well characterized. Here, we report that SARS-CoV-2 can directly infect human microglia, eliciting M1-like pro-inflammatory responses, followed by cytopathic effects. Specifically, SARS-CoV-2 infected human microglial clone 3 (HMC3), leading to inflammatory activation and cell death. RNA-seq analysis also revealed that ER stress and immune responses were induced in the early and apoptotic processes in the late phase of viral infection. SARS-CoV-2-infected HMC3 showed the M1 phenotype and produced pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumour necrosis factor α (TNF-α), but not the anti-inflammatory cytokine IL-10. After this pro-inflammatory activation, SARS-CoV-2 infection promoted both intrinsic and extrinsic death receptor-mediated apoptosis in HMC3. Using K18-hACE2 transgenic mice, murine microglia were also infected by intranasal inoculation of SARS-CoV-2. This infection induced the acute production of pro-inflammatory microglial IL-6 and TNF-α and provoked a chronic loss of microglia. Our findings suggest that microglia are potential mediators of SARS-CoV-2-induced neurological problems and, consequently, can be targets of therapeutic strategies against neurological diseases in COVID-19 patients. IMPORTANCE Recent studies reported neurological manifestations and complications in COVID-19 patients, which are associated with neuroinflammation. As microglia are the dominant immune cells in brains, it needs to be elucidate the relationship between neuroinflammation and host immune response of microglia to SARS-CoV-2. Here, we suggest that SARS-CoV-2 can directly infect human microglia with cytopathic effect (CPE) using human microglial clone 3 (HMC3). The infected microglia were promoted to pro-inflammatory activation following apoptotic cell death. This pro-inflammatory activation was accompanied by the high production of pro-inflammatory cytokines, and led to neurotoxic-M1 phenotype polarization. In vivo, murine microglia were infected and produced pro-inflammatory cytokines and provoked a chronic loss using K18-hACE2 mice. Thus, our data present that SARS-CoV-2-infected microglia are potential mediators of neurological problems in COVID-19 patients. In addition, HMC3 cells are susceptible to SARS-CoV-2 and exhibit the CPE, which can be further used to investigate cellular and molecular mechanisms of neuroinflammation reported in COVID-19 patients.

8 later gene expression changes contribute to apoptosis. In line with this, heatmap and network 161 analyses of GO biological processes using Metascape (Fig. 2F, 2G, Supplementary Fig. 4) , 162 immune responses, cytokine production, ER stress responses, and defense responses to virus 163 were distinctly enriched in S3, while apoptotic signaling pathway, negative regulation of cell 164 population, growth factor response were significantly altered in S6. To conclude, SARS-CoV-165 2 infection in HMC3 induced gene expression of antiviral immune and ER stress responses in 166 the early phase (S3) and of apoptosis in the late phase (S6). 167 168

In response to viral infection, microglia are activated and polarized into the pro-171 inflammatory M1 phenotype or the anti-inflammatory M2 phenotype (37). To assess the effects 172 of SARS-CoV-2 infection on microglial activation and polarization in HMC3, we analysed the 173 DEGs associated with immune response and microglial polarization. Several genes related to 174 type I IFNs and innate immunity such as MXs, the 2',5'-oligoadenylate synthetases (OASs), 175 and Complement component 3 (C3) were upregulated at 3 or 6 dpi in the RNA-seq data (Fig. 176 3A) . The M1 phenotype polarization related genes such as IL-1β, IL-6, and CXCL1 also 177 showed increased RNA expression levels ( Fig. 3B) , indicating that SARS-CoV-2 evoked pro-178 inflammatory activation and polarization toward the M1 phenotype in HMC3. To confirm this, 179

we assessed the expression of ILs and IFNs by ) and detected 180 secreted cytokines in culture media by enzyme-linked immunosorbent assay (ELISA) (Fig. 3C) . 181

Pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, but not the immune regulatory 182 cytokine IL-10, were highly produced and secreted by SARS-CoV-2 infection. CD68 is a 183 lysosomal protein expressed in high levels by macrophages and activated microglia and in low 9 levels by resting microglia (38) . The protein expression level of CD68 was increased in infected 185 HMC3 (Fig. 3D) , along with other makers of microglial pro-inflammatory activation such as 186 CX3CL1 and CX3CR1 (Fig. 3E) . These results evidently indicate that SARS-CoV-2-infected 187 HMC3 are pro-inflammatory activated. To verify whether activated microglia polarized into 188 the M1 phenotype, we estimated the RNA and protein expressions of the M1 phenotype 189 markers. When we assessed the RNA expression level of each representative marker of the M1 190 (NOS2) and M2 phenotypes (Arigase-1), only NOS2 was highly expressed at 6 dpi ( Fig. 3F) . 191 Protein expression levels of M1 markers, CD16, phospho-Stat1, and Stat1, were also induced 192 at 4 and 6 dpi ( ways (39) . To address the mechanism of cell death caused by SARS-CoV-2, we thought that 201 infected cells would die through apoptosis, which includes three major ways of programmed 202 cell death (PCD), such as necrosis and pyroptosis. Virtually, the expression of several genes 203 associated with apoptotic process in the DEGs were altered towards that of pro-apoptosis (Fig. 204 4A) . According to the western blotting of the proteins related to the apoptotic process, not only 205 extrinsic death-receptor mediated proteins (Fig. 4B ), but also those of the intrinsic pathways 206 ( Fig. 4C ) of apoptosis were elicited in the infected HMC3. Expression of death receptors such 207 as Fas, DR4, DR5, and TNF receptor 2 (TNFR2), which initiate extrinsic apoptosis, were 208 augmented at 4 and 6 dpi. On the other hand, the expression of an apoptosis regulator, 209 which suppresses apoptosis, was reduced, and those of Bim, Bid, and Bax, which are essential 210 for the activation of BAX-dependent PCD, were increased. Cleavages of caspase-9 in the 211 intrinsic pathway, caspase-8 in the extrinsic pathway, caspase-3, and poly (ADP-ribose) 212 polymerase (PARP) were observed, demonstrating both pathways of apoptosis (Fig. 4D ). Death 213 receptor-mediated apoptosis represents an efficient mechanism by which the virus can induce 214 cell death (39), and ER stress induced by viral infection is mainly involved in the intrinsic 215 pathway (34, 35) . Elicited apoptosis in the infected HMC3 was confirmed by Annexin V 216 staining (Fig. 4E ). To confirm apoptosis, we measured the survived cells at 6 dpi via crystal 217 violet staining following the treatment of potent and selective inhibitors against Caspases. The 218 treatments of Z-DEVD-FMK (Caspase-3 inhibitor), Z-IETD-FMK (Caspase-8 inhibitor), and 219 Z-VAD-FMK (pan-Caspase inhibitor) significantly blocked the apoptotic cell death (Fig. 4F) . 220

Since RNA viruses such as Vesicular Stomatitis Virus (VSV), Encephalomyocarditis 221 Virus (EMCV), and Zika virus (ZIKV) promote inflammatory cell death, such as pyroptosis, 222 in most immune cells (40, 41), we assessed the possibility of pyroptosis induced by SARS-223

CoV-2 infection in HMC3. We observed no changes in the protein expression levels of NLR 224 family pyrin domain containing 3 (NLRP3), or the cleavage of gasdermin D (GSDMD) and 225 caspase-1, which suggests that pyroptosis might not have been promoted in SARS-CoV-2-226 infected HMC3 (Fig. 5A ). The treatments of Ac-FLTD-CMK (Caspase-1 inhibitor) and 227

Belnacasan (VX-765, Caspase-1 inhibitor) as described above also did not recover the cell 228 viability (Fig. 5B ). Taken together, these results suggest that SARS-CoV-2 induces cell death 229 in HMC3 through both intrinsic and extrinsic death receptor-mediated apoptosis pathways. 230

To substantiate these viral infection and microglial activation in vivo model, we used 234 transgenic mice expressing the human ACE2, driven by the cytokeratin-18 gene promoter 235 (K18-hACE2 mice), which were established for a model of SARS-CoV-2 infection and viral 236 spread through the olfactory pathway (42-44). We inoculated 8-week-old heterozygous male 237 K18-hACE2 mice via the intranasal route with 2 × 10 4 plaque-forming units (pfu) of SARS-238

CoV-2. At 6 days post-infection (dpi), infected mice showed a marked weight loss that was 239 approximately 20 % of their body weight (Fig. 6A) . The viral RNA was detected from the 240 brains of SARS-CoV-2 infected mice (Fig. 6B) . Notably, the co-localization of SARS-CoV-2 241 spike protein (S) and Iba1, most commonly used marker of microglia, was detected mostly at 242 6 dpi in the brains (Fig. 6C ). From these results, we suggest SARS-CoV-2 infection of 243 microglia in vivo model. 244

To confirm that SARS-CoV-2 infection of microglia induces pro-inflammatory 245 activation following cell death in these mice, their brain homogenates were used to isolate 246 leukocytes containing microglia by 30 % and 70 % Percoll discontinuous gradient 247 centrifugation, followed by flow cytometry analysis with cell surface markers of microglia, 248

CD11b and CD45 as illustrated in Fig. 7A . The isolate consisted of three separated populations, 249 including that of lymphocytes (CD11b -, CD45 High ), macrophages (CD11b + , CD45 High ), and 250 microglia (CD11b + , CD45 Low ) (45). While microglia account for most CNS leukocytes of 251 uninfected mice, SARS-CoV-2 infection altered their population (Fig. 7B ). Microglia were 252 significantly depopulated by SARS-CoV-2 infection (Fig. 7C ). On the other hand, the numbers 253 of infiltrated lymphocytes and macrophages were dramatically increased about seven times 254 ( Fig. 7D, 7E ). We also found that most microglia were activated with the high expressions of such as microgliosis, immune cell infiltration, and cell death in vivo. 258

Although COVID-19 is primarily known as a respiratory disease, symptoms related to 261 changes in the peripheral nervous system have recently been reported in the patients (15). There 262 is evidence of viral invasion into the brain through the olfactory or vagal nerve and/or the oral 263 and ophthalmic routes, with trans-synaptic neuronal spread to other brain regions in COVID-264 19 patients' autopsy and SARS-CoV-2-infected mice model (25, 29, 46) . Microglia, expressing 265 SARS-CoV-2 entry factors, including ACE2 and TMPRSS2 (30) In this study, first, we found that SARS-CoV-2 directly infects a human microglial cell 276 line. Regarding the RNA-seq analysis, it was observed that the viral infection induced ER stress 277 and immune responses in the early phase and apoptosis in the late phase. Practically, the 278 microglia, infected with SARS-CoV-2, were activated and polarized toward the M1 phenotype, 279 the mediator of pro-inflammatory responses. In addition, SARS-CoV-2 infection triggered 280 apoptosis as one of the CPE in human microglia through both the intrinsic and extrinsic 281 pathways, further provoking cell death. Indeed, SARS-CoV-2 has been reported to induce both 282 the intrinsic and extrinsic apoptosis in lung tissues and cell lines (52). More recently, SARS-283

CoV-2-encoded membrane glycoprotein (M) and NP have been demonstrated to trigger 284 apoptosis (53), suggesting a mechanism of apoptosis in SARS-CoV-2-infected microglia. 285

Moreover, we observed SARS-CoV-2 infection of microglia in K18-hACE2 mice, followed by 286 an increase in the number of activated microglia and immune cell accumulation in the brain, 287 and a decrease of the total number of microglia. 288

Given the co-localization of viral proteins and Iba1 in brains of COVID-19 patients by 289 post-mortem studies (32, 49), we herein suggest a possibility that SARS-CoV-2 directly infects 290 human microglia, inducing the CPE, which is cell death. Also, human microglia could be one 291 of models to study viral pathogenesis. Microglia are important not only for the innate, but also 292 for the adaptive immune responses to pathogen infection of the brain (54). Depletion of 293 microglia can lead to ineffective T cell responses by reduction of the total number and 294 percentage of CD4 + and regulatory T cells. Consequently, the depletion of microglia causes 295 increased viral replication and increased neurological manifestations in the brain (55, 56). 296 Therefore, microglial cell death by SARS-CoV-2 infection might be linked to the lack of 297 immune response and consequent increased viral replication, leading to increased neurological 298 manifestations. 299

The activation of microglia and complement-mediated pathways, which leads to the 300 synthesis of inflammation mediators, is the key element of main inflammatory neurological 301 diseases (57). Virtually, many viruses, including the HIV-1, Herpes Simplex Virus (HSV), and 302 ZIKV, infect microglia and cause neuroinflammation via microglial activation. C3 and its 303 cleavage products attract microglia to gather around the neurons to exert phagocytosis activity 304 and to clear the presynaptic ends (58). The increase in the number of activated microglia via 305 viral infection can have detrimental effects, indirectly by activating astrocytes (59) and T lead to increased blood-brain barrier (BBB) breakdown and might be responsible for several 309 neurological symptoms of COVID-19 (47). Thus, microglia could be a potential target for 310 SARS-CoV-2 and could help the spread of the virus in the CNS. In future study, to gain more 311 insights into the SARS-COV-2 neuropathology in COVID-19 patients, it will be important to 312 consider of the relationship between SARS-CoV-2 and microglia. Taken Cells (1 × 10 5 cells per well) were plated into six-well plates and inoculated with one 327 multiplicity of infection (MOI) SARS-CoV-2 in EMEM containing 2 % FBS on the next day. 328

After incubation for 1 h, the inoculum was removed, and the cells were washed two times. The 329 medium was changed to EMEM containing 10 % FBS. At 2, 4, or 6 dpi, the total cellular RNA neutralization, the inoculum was further incubated with CR3022 neutralizing antibody 332 regulation of proteolysis apoptotic signaling pathway negative regulation of intracellular signal transduction cellular response to tumor necrosis factor regulation of cellular response to stress regulation of cytokine production inflammatory response response to interferon-gamma response to endoplasmic reticulum stress negative regulation of cell population proliferation cellular response to organic cyclic compound regulated exocytosis blood vessel development carbohydrate metabolic process reproductive structure development import into cell epithelial cell proliferation endothelium development lipid localization cellular response to abiotic stimulus regulation of cell adhesion response to inorganic substance response to growth factor multicellular organismal homeostasis negative regulation of cell differentiation positive regulation of proteolysis cellular response to external stimulus positive regulation of interleukin-8 production 

The role of microglia in viral encephalitis: a review

Enhanced viral clearance and reduced leukocyte infiltration in 658 experimental herpes encephalitis after intranasal infection of CXCR3-deficient mice

T cells promote 661 microglia-mediated synaptic elimination and cognitive dysfunction during recovery from 662 neuropathogenic flaviviruses

Long-term 664 microgliosis driven by acute systemic inflammation

Isolation of murine microglial cells 667 for RNA analysis or flow cytometry

Isolation and analysis of mouse microglial cells. 669 Current protocols in immunology

Cutadapt removes adapter sequences from high-throughput sequencing 671 reads

STAR: ultrafast universal RNA-seq aligner

HTSeq-a Python framework to work with high-throughput 675 sequencing data

Moderated estimation of fold change and dispersion for 677 RNA-seq data with DESeq2

Enrichr: a comprehensive gene set enrichment analysis 680 web server 2016 update

Metascape provides a biologist-oriented resource for the analysis of systems-level 683 datasets